Trials / Withdrawn
WithdrawnNCT00958425
Intraoperative Hyaluronic Acid Gel Injection for Improvement of Scar Quality Following Reduction Mammaplasty
Intraoperative Hyaluronic Acid Gel Injection for Improvement of Scar Quality Following Reduction Mammaplasty: a Phase III Double-blinded, Single-centred, Randomized Controlled Study
- Status
- Withdrawn
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Nova Scotia Health Authority · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine the efficacy of hyaluronic acid gel injections compared to saline injections in improving scar quality in patients undergoing breast reduction surgery. Hyaluronic acid has been implicated in scarless fetal healing, and the investigators therefore hypothesize that injections of hyaluronic acid gel into breast reduction incisions will improve their appearance compared to injections of saline.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Hyaluronic acid gel | Hyaluronic acid gel (20 mg/mL), 0.9 mL, intradermal over 2 cm area, once |
| DEVICE | Saline | Normal saline, 0.9 mL, intradermal over 2 cm area, once |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2014-01-01
- Completion
- 2014-01-01
- First posted
- 2009-08-13
- Last updated
- 2024-08-21
Source: ClinicalTrials.gov record NCT00958425. Inclusion in this directory is not an endorsement.